Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colgate-Palmolive

This article was originally published in The Tan Sheet

Executive Summary

Nineteen new products are scheduled to be introduced in 2000, compared to 14 last year and 12 in 1998, the firm states July 20. Recent dentifrice extensions include Colgate Sensitive and Sparkling White, which helped increase Colgate's market share 1.5 points to 32.1%, and the upcoming Colgate 2in1 toothpaste/mouthwash combo (1"The Tan Sheet" July 10, p. 8). North American sales, which accounted for 24% of the company's total second quarter sales, were up 8% to $560 mil., while unit volume increased 7%. Colgate's consolidated sales rose 2.2% to $2.34 bil. and income was up 14.8% to $261.9 mil

You may also be interested in...



Colgate Total Whitening Extension Set For Late Fourth Quarter

Colgate-Palmolive's new product program helped propel North American sales 11% to $591.6 mil. for the third quarter, the company announced during an analysts conference call Oct. 24.

Colgate Total Whitening Extension Set For Late Fourth Quarter

Colgate-Palmolive's new product program helped propel North American sales 11% to $591.6 mil. for the third quarter, the company announced during an analysts conference call Oct. 24.

Colgate Total Whitening Extension Set For Late Fourth Quarter

Colgate-Palmolive's new product program helped propel North American sales 11% to $591.6 mil. for the third quarter, the company announced during an analysts conference call Oct. 24.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091454

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel